Results 1 to 10 of about 4,423,512 (307)

Global incidence, risk factors and trends of vulvar cancer:a country-based analysis of cancer registries [PDF]

International Journal of Cancer, 2023
Vulvar cancer is an uncommon malignancy. Vulvar cancer alarmed the public health problem in terms of the cost of diagnostic and medical treatments and psychical health of females. Our study aims to provide a thorough analysis of the global disease burden,
Chan, Sze Chai, Elcarte, Edmar, Fung, Yat Ching, Huang, Junjie, Lin, Xu, Lok, Veeleah, Lucero-Prisno III, Don Eliseo, Mak, Fung Yu, Pang, Wing Sze, Withers, Mellissa, Wong, Martin C.S., Xu, Wanghong, Zhang, Lin, Zheng, Zhi-Jie   +13 more
core   +2 more sources

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. [PDF]

Int J Gynecol Cancer, 2023
Background As part of its mission to improve the quality of care for women with gynecological cancers across Europe, the European Society of Gynaecological Oncology (ESGO) first published in 2017 evidence-based guidelines for the management of patients ...
Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D, Creutzberg CL, Guillot E, Garganese G, Lax S, Redondo A, Sturdza A, Taylor A, Ulrikh E, Vandecaveye V, van der Zee A, Wölber L, Zach D, Zannoni GF, Zapardiel I.   +19 more
europepmc   +2 more sources

The Impact of Vulvar Cancer on Psychosocial and Sexual Functioning: A Literature Review [PDF]

Cancers, 2021
SIMPLE SUMMARY: The diagnostic and therapeutic pathway of vulvar cancer impacts severely on the psychosocial and psychosexual equilibrium of women affected by it. The current literature shows the presence of depressive and anxious symptoms in association
Benedetto, Chiara, Bevilacqua, Federica, Carletto, Sara, Gallio, Niccolò, Malandrone, Francesca, Merola, Mariagrazia, Ostacoli, Luca   +6 more
core   +2 more sources

Management of Early-Stage Vulvar Cancer. [PDF]

Cancers (Basel), 2022
Simple Summary Vulvar cancer is a rare gynecological malignancy that affects mainly postmenopausal women. Recently, however, an alarming increase in the rates among young women has been observed due to human papillomavirus infection.
Pedrão PG, Guimarães YM, Godoy LR, Possati-Resende JC, Bovo AC, Andrade CEMC, Longatto-Filho A, Dos Reis R.   +7 more
europepmc   +2 more sources

Vulvar cancer management and wrangling recurrent disease: A report from the society of gynecologic oncology journal club [PDF]

Gynecologic Oncology Reports, 2023
The Society of Gynecologic Oncology (SGO) Journal Club webinar series is an open forum that invites national experts to discuss the literature pertaining to important topics in the management of gynecologic cancers.
Jessica E. Parker, Emi J. Yoshida, Lilian T. Gien, Brian M. Slomovitz, Christa Nagel   +4 more
doaj   +2 more sources

Factors associated with vulvar cancer from 2005 to 2021 in Togo, sub-Saharan Africa [PDF]

BMC Women's Health, 2023
Background vulvar cancer, once predominantly diagnosed in older women, is increasingly being diagnosed in younger individuals, due to Human Papillomavirus (HPV) infection.
Tchin Darré, Bagassam Sama, Toukilnan Djiwa, Whitney E.D. Afantodji-Agbeti, Mayi Bombone, Yendoubé Kambote, Panakinao Simgban, Bingo K M’Bortche, Baguilane Douaguibe, Koffi Amégbor, Mazamaesso Tchaou, Abdoul-Samadou Aboubakari, Bayaki Saka, Gado Napo-Koura   +13 more
doaj   +2 more sources

Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report [PDF]

Gynecologic Oncology Reports
There is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer, M. Larissa Weirich, Zoe A. Roecker, Sara E. Brenner, Jill S. Remick, Ashish B. Patel, Kristen D. Starbuck   +6 more
doaj   +2 more sources

Incidence Trends of Vulvar Cancer in the United States: A 20‐Year Population‐Based Study [PDF]

Cancer Reports
Background Despite being uncommon, vulvar cancer is a serious health concern with a 5‐year relative survival rate of 71%. Aims The objective was to investigate the incidence rates of this disease across different racial, ethnic, and histological ...
Seyed Ehsan Mousavi, Hoomaan Ghasemi, Morvarid Najafi, Zahra Yekta, Seyed Aria Nejadghaderi   +4 more
doaj   +2 more sources

Treatment of vulvar cancer recurrence with electrochemotherapy: a case-control study [PDF]

Acta Oncologica
Background: Electrochemotherapy (ECT) is a combined treatment method based on electroporation and simultaneous chemotherapy. In cases where radiotherapy has previously been used, surgery is often the only treatment option for vulvar cancer recurrence ...
Gregor Vivod, Masa Omerzel, Nina Kovacevic, Gorana Gasljevic, Ines Cilensek, Gregor Sersa, Maja Cemazar, Sebastjan Merlo   +7 more
doaj   +2 more sources

Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study [PDF]

BMC Cancer, 2011
Background Epigenetic regulation is an important mechanism leading to cancer initiation and promotion. Histone acetylation by histone deacetylases (HDACs) represents an important part of it.
Samartzis Nicolas, Imesch Patrick, Dedes Konstantin J, Samartzis Eleftherios P, Fedier André, Fink Daniel, Caduff Rosmarie, Fehr Mathias K   +7 more
doaj   +6 more sources